CAMBREX CORP 3 SEC Filings

Filed On	Filing
12 Jun 2019	Form 3: Donnelly-Brienza Dorothy A, SVP & CHRO Holds 0 shares of Common Stock
02 Nov 2017	Form 3: Brown Gregory B, Director No securities owned
23 Jan 2017	Form 3: Vadaketh Tom George, Executive Vice President & CFO
31 Oct 2016	Form 3: Hampl Bernard Dr, Director No securities owned
25 Mar 2016	Form 3: Glassell Claes, Director No securities owned
04 Nov 2015	Form 3: Grabowsky Louis J., Director No securities owned
03 Feb 2015	Form 3: Hanley Samantha, Vice President Holds 0 shares of Common Stock
30 May 2014	Form 3: Winschel James F Jr, Director Holds 750 shares of Common Stock
29 Nov 2012	Form 3: Yanai Shlomo, Director Holds 0 shares of Common Stock
30 Jun 2011	Form 3: Haskel William M., Senior Vice President Holds 0 shares of Common Stock
24 Jan 2011	Form 3: Cavanagh Shawn, Executive Vice President & COO Holds 0 shares of Common Stock
24 Feb 2010	Form 3: Magnini Aldo, Managing Director, Profarmaco Holds 34,542 shares of Common Stock
13 Feb 2009	Form 3: Zachara F. Michael, Vice President
02 Nov 2006	Form 3: Anup Gupta, Vice President & Treasurer Holds 1,000 shares of Common Stock
16 Feb 2006	Form 3: Cavanagh Shawn, Senior VP/GM, Biopharma Holds 2,989 shares of Common Stock
03 Jun 2005	Form 3: Bethune David R, Director Holds 0 shares of Common Stock
19 Apr 2005	Form 3: Congiusti Robert J, Vice President Holds 5,500 shares of Common Stock
24 Aug 2004	Form 3: Leone John R, President & CEO Holds 0 shares of Common Stock
26 Nov 2003	Form 3: Eansor N David, President, BioProductsBus Unit Holds 10,500 shares of Common Stock

Comments